Recurrent cutaneous leishmaniasis

Strick, Richard A.; Borok, Michael; Gasiorowski, Henry C.

doi:10.1016/s0190-9622(83)70156-8

Cited by 29 publications

(6 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The resemblance between these two diseases is so close that “apple‐jelly” nodules are also often seen on diascopy 70 . The recidivans form of CL may manifest after complete healing of the primary lesion with recurrence months or years later in the vicinity of the scar 42,71,72 . This form presents with new gyrate and annular lesions that develop around dusky‐red, partially scarred, plaques with active, spreading borders at previously healed sites.…”

Section: True Cutaneous Leishmaniasismentioning

confidence: 99%

Clinical manifestations and classification of Old World cutaneous leishmaniasis

2007

View full text Add to dashboard Cite

Section: True Cutaneous Leishmaniasismentioning

confidence: 99%

Clinical manifestations and classification of Old World cutaneous leishmaniasis

2007

View full text Add to dashboard Cite

“…An event observed so far only in Central and South America, many researchers in the field have demonstrated metastasis by various means. 21,[32][33][34] Meanwhile several researchers have attempted parasite isolation from peripheral blood, but few have been successful 35 and several others have failed. 21,32 We have previously reported, on two occasions, what are considered very unusual cases.…”

Section: Discussionmentioning

confidence: 99%

Detection of Leishmania parasites in the blood of patients with isolated cutaneous leishmaniasis

Chmaisse

Makki

Nahhas

et al. 2011

International Journal of Infectious Diseases

View full text Add to dashboard Cite

In the current study, the detection rate of parasites in the blood of patients with cutaneous leishmaniasis was high. This illustrates the invasive characteristic of the parasite that has escaped the skin. Testing should be considered in areas other than Lebanon, especially around the Mediterranean basin. Whether these findings support the administration of systemic treatment for cutaneous leishmaniasis or not needs to be confirmed in larger prospective studies.

show abstract

“…9–10 Our patient declined excision with grafting of residual scar tissue, which is suggested in the literature. 11 …”

Section: Discussionmentioning

confidence: 99%

Leishmaniasis recidiva cutis

2000

View full text Add to dashboard Cite

A 62‐year‐old white woman presented with an 8‐month history of a slowly and progressively growing, erythemato‐infiltrative plaque on her right temporo‐malar region. The lesion was originally described as reddish, confluent papules, expanding at the periphery and leaning towards the scarring resolution in the central area. Physical examination revealed an extensive atrophic area, of 4 cm in diameter, with confluent, small, yellow‐brown, scaly papules surrounding it, localized on the right temporo‐malar region ( Fig. 1). On diascopy, ‘‘apple‐jelly‐like nodules’' were seen at the periphery. A complete clinical evaluation showed the patient in good health. The results of the routine laboratory tests were normal. 1 Extensive atrophic plaque with dusky hypertrophic border of the face A punch‐biopsy (3 mm in diameter) was performed at the border of the plaque for histologic study. The tissue sections, stained with hematoxylin and eosin, showed acanthosis and a granulomatous dermal infiltrate composed of lymphohistiocytic cells, a few plasma cells, and Langhans epithelial giant cells ( Fig. 2). No areas of necrosis were seen. The apposition of the skin biopsy, followed by the May‐Grunwald stain, showed rare Leishman's bodies. 2 Histopathology of the skin „lesion showing typical granulomatous dermal infiltrate During detailed questioning, the patient stated that 1 year previously a micropapular lesion, mosquito‐bite‐like, appeared in the same area of the present plaque and healed after 2 weeks of therapy with an undefined topical antibiotic. These anamnestic data, together with the clinical and histopathologic findings, support the diagnosis of leishmaniasis recidiva cutis (LRC). The patient was treated with intralesional meglumine antimonate (Glucantim) (twice in a week for 3 weeks). At the end of therapy an atrophic plaque remained. After 5 years of follow‐up no relapses were found.

show abstract

Recurrent cutaneous leishmaniasis

Cited by 29 publications

References 33 publications

Clinical manifestations and classification of Old World cutaneous leishmaniasis

Clinical manifestations and classification of Old World cutaneous leishmaniasis

Detection of Leishmania parasites in the blood of patients with isolated cutaneous leishmaniasis

Leishmaniasis recidiva cutis

Contact Info

Product

Resources

About